Skip to content
DataLookout
Menu

NCT06972576

Clinical Study of Combined EphA2-targeted CAR-DC and CAR-T Cell Therapy for Non-small Cell Lung Cancer

StatusWithdrawn
PhasePhase 1
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Stopped Trial status changed: Recruiting → Withdrawn Sponsor's reason: Policy change Show 6 more changesShow less
    • Primary completion date changed from estimate of Apr 2026 to Oct 27, 2026
    • Enrollment target: estimated 18 to confirmed 0
    • Eligibility criteria shortened, about 1 word
    • Study completion date changed from estimate of Apr 2027 to Oct 28, 2026
    • Secondary endpoints: details revised at 3 of 7 entries
    • Site details revised
  2. Notable Changed Sponsor changed: Second Affiliated Hospital, School of Medicine, Zhejiang University to Second Affiliated Hospital, Zhejiang University, School of Medicine
  3. Study First Submitted
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed

Endpoints

Primary

Safety: Incidence and severity of adverse events
Timeframe: First 3 month post CAR-T cells and CAR-DCs infusion
Efficacy: Remission Rate
Timeframe: 3 months post CAR-T cells and CAR-DCs infusion

Secondary (7)

Progression-Free Survival
Overall Survival
Relapse Rate
Duration of Response
In Vivo Persistence of CAR-T cells and CAR-DCs and Cytokine Profile Monitoring
Show 2 moreShow less
Objective Response Rate in Participants Receiving Different Doses of CAR-DCs
Incidence and Severity of Treatment-Related Adverse Events in Participants Receiving Different Doses of CAR-DCs

Arms and interventions

CAR-T and CAR-DC Combination TherapyExperimental

This arm involves the sequential administration of two biological interventions with EphA2-targeted CAR-DCs administered first, followed by EphA2-targeted CAR-T cells.

Biologicals: EphA2-targeted CAR-T Cells, EphA2-targeted CAR-DCs

Sites

1 site in 1 country

  • Second Affiliated Hospital, School of Medicine, Zhejiang UniversityHangzhou, Zhejiang, China